The news came out today. Not only was it approved but it was fast-tracked. The drug is for breast cancer, but does not treat all patients with breast cancer. It seems to only work on a certain type of cancer. It also does not have any impact on the tumor., but it does attack the cancer in the tumor.
In short, the drug seems to only be effective in certain women with breast cancer, and only extends the survival time by a small number. Yet it was fast-tracked and FDA approved today.
Amazing how the FDA can recognize an effective treatment and then fast track it...when did you say the FDA was going to fast track ADXS-HPV?
ADXS construct for breast cancer would go after same exact antigen, and therefore be effective in the same percentage of women with breast cancer (HER2+).
I just saw a segment on FOX news about Kadcyla. It is being hearlded as a "AMAZING BREAKTHORUGH" in cancer treatment with tumor shrinkage with no other tissue damage.
Per Fox news it was rapidly approved by the FDA after clinical tests showed it helped 20% of breast cancer patients survive an additional 3.5 months. To repeat 20% with an additional 3.5 months survival.
That sort of shed a different light on the India trial numbers to some saying 33% living additional 6 months longer than expected is a low number.
Thanks PRD, i didn't find the original post too be worth much but you made it relevant - quite well.
read the side effects,safer options will retire this drug early
Media makes it sound great but it is still "old tech" chemo poison. Facny delivery system is all. We are as different from it as modern medicine to medieval medicine.
From my limited understanding it looks like it as exactly what you described. A targeted delivery system delivering chemo only targeting cancer cells. Old school but still a good improvement from currently approved options.
Hey, Jham...
Looks like we travel in the same circles? lol
minnesota,
It sure seems that way. You should come over to the "dark side" :) We have some very familiar names discussing ADXS at iHam.
I hearya. How ADXS is sitting only at .13 with what they have is amazing. Could see .25 next week even on no news imo. Good news and race to .50+ is on likely. Have a great weekend all